China Resources Medical Holdings Company Limited (1515.HK)
HKD 3.65
(-1.62%)
HKD 3.65
(-1.62%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.9 Billion CNY | 96.25% |
| 2022 | 971.14 Million CNY | 4.03% |
| 2021 | 933.55 Million CNY | 46.67% |
| 2020 | 636.5 Million CNY | -16.5% |
| 2019 | 762.29 Million CNY | 0.74% |
| 2018 | 756.67 Million CNY | 13.23% |
| 2017 | 668.23 Million CNY | 64.33% |
| 2016 | 406.63 Million CNY | 23.38% |
| 2015 | 329.58 Million CNY | 10.71% |
| 2014 | 297.7 Million CNY | 39.97% |
| 2013 | 212.69 Million CNY | 15.09% |
| 2012 | 184.8 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 1.03 Billion CNY | 0.0% |
| 2023 Q2 | 1.08 Billion CNY | 0.0% |
| 2023 FY | 1.9 Billion CNY | 96.25% |
| 2023 Q4 | 816.34 Million CNY | 0.0% |
| 2022 Q2 | 605.46 Million CNY | 0.0% |
| 2022 FY | 971.14 Million CNY | 4.03% |
| 2022 Q4 | 700.35 Million CNY | 0.0% |
| 2021 Q2 | 394.57 Million CNY | 0.0% |
| 2021 FY | 933.55 Million CNY | 46.67% |
| 2021 Q4 | 538.98 Million CNY | 0.0% |
| 2020 Q2 | 245.32 Million CNY | 0.0% |
| 2020 Q4 | 391.18 Million CNY | 0.0% |
| 2020 FY | 636.5 Million CNY | -16.5% |
| 2019 Q4 | 416.72 Million CNY | 0.0% |
| 2019 FY | 762.29 Million CNY | 0.74% |
| 2019 Q2 | 345.56 Million CNY | 0.0% |
| 2018 Q4 | 398.6 Million CNY | 0.0% |
| 2018 Q2 | 358.07 Million CNY | 0.0% |
| 2018 FY | 756.67 Million CNY | 13.23% |
| 2017 Q4 | 345.12 Million CNY | 0.0% |
| 2017 FY | 668.23 Million CNY | 64.33% |
| 2017 Q2 | 323.1 Million CNY | 0.0% |
| 2016 Q2 | 182.07 Million CNY | 0.0% |
| 2016 Q4 | 224.55 Million CNY | 0.0% |
| 2016 FY | 406.63 Million CNY | 23.38% |
| 2015 Q2 | 141.55 Million CNY | 0.0% |
| 2015 FY | 329.58 Million CNY | 10.71% |
| 2015 Q4 | 188.02 Million CNY | 0.0% |
| 2014 Q4 | 178.35 Million CNY | 0.0% |
| 2014 FY | 297.7 Million CNY | 39.97% |
| 2014 Q2 | 119.34 Million CNY | 0.0% |
| 2013 FY | 212.69 Million CNY | 15.09% |
| 2013 Q4 | 125.27 Million CNY | 0.0% |
| 2013 Q2 | 87.42 Million CNY | 0.0% |
| 2012 Q1 | 46.2 Million CNY | 0.0% |
| 2012 Q3 | 46.2 Million CNY | 0.0% |
| 2012 FY | 184.8 Million CNY | 0.0% |
| 2012 Q4 | 53.17 Million CNY | 15.09% |
| 2012 Q2 | 46.2 Million CNY | 0.0% |
| 2011 Q4 | 46.2 Million CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Aidigong Maternal & Child Health Limited | 121.03 Million HKD | -1474.655% |
| UMP Healthcare Holdings Limited | 692.25 Million HKD | -175.31% |
| Human Health Holdings Limited | 271.41 Million HKD | -602.191% |
| EuroEyes International Eye Clinic Limited | 316.8 Million HKD | -501.588% |
| Kato (Hong Kong) Holdings Limited | 95.46 Million HKD | -1896.477% |
| Bamboos Health Care Holdings Limited | 84.71 Million HKD | -2149.651% |
| Beijing Health (Holdings) Limited | 38.47 Million HKD | -4853.571% |
| C-MER Eye Care Holdings Limited | 542.46 Million HKD | -251.331% |
| Town Health International Medical Group Limited | 367.94 Million HKD | -417.974% |
| Medicskin Holdings Limited | 14.76 Million HKD | -12806.928% |
| Hang Chi Holdings Limited | 51.13 Million HKD | -3626.997% |